News preview — no account needed

Neuvotion Launches First FDA-Cleared Product From Its Brain-Body Interface Platform

BioSpace · July 27, 2026

Preview

Neuvotion, founded by Chad Bouton to commercialize the research behind his Feinstein Institutes 'double neural bypass' work, announced its first FDA-cleared product: NeuStim, a non-invasive, AI-guided electrical muscle stimulation device for stroke and…

The complete summary, “why it matters” analysis and the original source link are available to members.

NeurostimulationAI/ML